Cronin, M.; Crowley, A.; Davey, M.G.; Ryan, P.; Abdelshafy, M.; Elkoumy, A.; Elzomor, H.; Arsang-Jang, S.; Ganly, S.; Nash, P.;
et al. Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer. J. Clin. Med. 2023, 12, 1278.
https://doi.org/10.3390/jcm12041278
AMA Style
Cronin M, Crowley A, Davey MG, Ryan P, Abdelshafy M, Elkoumy A, Elzomor H, Arsang-Jang S, Ganly S, Nash P,
et al. Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer. Journal of Clinical Medicine. 2023; 12(4):1278.
https://doi.org/10.3390/jcm12041278
Chicago/Turabian Style
Cronin, Michael, Aileen Crowley, Matthew G. Davey, Peter Ryan, Mahmoud Abdelshafy, Ahmed Elkoumy, Hesham Elzomor, Shahram Arsang-Jang, Sandra Ganly, Patrick Nash,
and et al. 2023. "Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer" Journal of Clinical Medicine 12, no. 4: 1278.
https://doi.org/10.3390/jcm12041278
APA Style
Cronin, M., Crowley, A., Davey, M. G., Ryan, P., Abdelshafy, M., Elkoumy, A., Elzomor, H., Arsang-Jang, S., Ganly, S., Nash, P., Crowley, J., Sharif, F., Simpkin, A., Lowery, A., Wijns, W., Kerin, M., & Soliman, O.
(2023). Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer. Journal of Clinical Medicine, 12(4), 1278.
https://doi.org/10.3390/jcm12041278
